{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:04:20Z","timestamp":1744142660734},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/yco.0b013e32832a1dc0","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T11:14:53Z","timestamp":1242904493000},"page":"274-280","source":"Crossref","is-referenced-by-count":19,"title":["The implications of medication development in the treatment of substance use disorders in developing countries"],"prefix":"10.1097","volume":"22","author":[{"given":"Jagadisha","family":"Thirthalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat K","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210206","first-page":"639","article-title":"Substance use problems in developing countries","volume":"82","author":"Uchtenhagen","year":"2004","journal-title":"Bulletin of World Health Organisation"},{"key":"R2-6-20210206","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1360-0443.2005.01176.x","article-title":"India: alcohol and public health","volume":"100","author":"Benegal","year":"2005","journal-title":"Addiction"},{"key":"R4-6-20210206","first-page":"5","article-title":"Alcohol use disorders among Nigerian University students: prevalence and sociodemographic correlates","volume":"5","author":"Adewuya","year":"2007","journal-title":"Nigeria J Psychiatry"},{"key":"R5-6-20210206","first-page":"641","article-title":"Substance use problems in developing countries","volume":"82","author":"Uchtenhagen","year":"2004","journal-title":"Bull World Health Org"},{"key":"R7-6-20210206","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","article-title":"Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys","volume":"5","author":"Degenhardt","year":"2008","journal-title":"PLoS Med"},{"key":"R11-6-20210206","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/YCO.0b013e3282fc1ea3","article-title":"Drug and alcohol services in middle-income countries","volume":"21","author":"Perngparn","year":"2008","journal-title":"Curr Opin Psychiatry"},{"issue":"Suppl 3","key":"R13-6-20210206","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2146\/ajhp060644","article-title":"Emerging approaches to managing alcohol dependence","volume":"64","author":"Swift","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"R14-6-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0269881107078308","article-title":"Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes","volume":"22","author":"R\u00f6sner","year":"2008","journal-title":"J Psychopharmacol"},{"key":"R15-6-20210206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R16-6-20210206","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study \u2013 a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"R17-6-20210206","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.ALC.0000130804.08397.29","article-title":"Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial","volume":"28","author":"Kranzler","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R18-6-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1360-0443.2004.00597.x","article-title":"Does disulfiram have a role in alcoholism treatment today?","volume":"99","author":"Fuller","year":"2004","journal-title":"Addiction"},{"key":"R19-6-20210206","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1360-0443.2004.00779.x","article-title":"The revival (or, rather, survival) of disulfiram","volume":"99","author":"Grover","year":"2004","journal-title":"Addiction"},{"key":"R20-6-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/alcalc\/agm136","article-title":"A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence","volume":"43","author":"Laaksonen","year":"2008","journal-title":"Alcohol Alcohol"},{"key":"R21-6-20210206","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R22-6-20210206","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.addbeh.2007.11.011","article-title":"A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence","volume":"33","author":"Pettinati","year":"2008","journal-title":"Addict Behav"},{"key":"R23-6-20210206","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"key":"R24-6-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15622970801896390","article-title":"World Federation of societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders. Part I: Alcoholism","volume":"9","author":"Soyka","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"R25-6-20210206","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomized, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"R26-6-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technol Assess"},{"key":"R27-6-20210206","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"N Engl J Med"},{"key":"R28-6-20210206","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1360-0443.2005.01039.x","article-title":"The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001\u201303","volume":"100","author":"De Wet","year":"2005","journal-title":"Addiction"},{"key":"R30-6-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0975156419880213","article-title":"An experience with disulfiram in the management of alcohol dependence syndrome","volume":"11","author":"Krishna Murthy","year":"1988","journal-title":"Indian J Psychol Med"},{"key":"R31-6-20210206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/alcalc\/agh187","article-title":"An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence","volume":"40","author":"de Sousa","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"R32-6-20210206","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/alcalc\/agh104","article-title":"A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence","volume":"39","author":"De Sousa","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"R33-6-20210206","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jsat.2007.05.012","article-title":"An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence","volume":"34","author":"De Sousa","year":"2008","journal-title":"J Subst Abuse Treat"},{"issue":"4 Suppl","key":"R35-6-20210206","first-page":"5","article-title":"Treatment of patients with substance use disorders, second edition. American Psychiatric Association","volume":"164","author":"Kleber","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R36-6-20210206","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(08)60954-X","article-title":"Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Schottenfeld","year":"2008","journal-title":"Lancet"},{"key":"R37-6-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.drugalcdep.2007.11.008","article-title":"Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial","volume":"94","author":"Chawarski","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R38-6-20210206","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"R39-6-20210206","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1037\/0022-006X.69.3.389","article-title":"Meta-analysis of HIV risk reduction interventions with drug abuse treatment programs","volume":"69","author":"Prendergast","year":"2001","journal-title":"J Consult Clin Psychol"},{"key":"R42-6-20210206","first-page":"S16","article-title":"Alcohol dependence related outcome with disulfiram therapy","volume":"50","author":"Savitha","year":"2008","journal-title":"Indian J Psychiatry"},{"key":"R43-6-20210206","first-page":"34","article-title":"Substance abuse intervention in South Africa","volume":"4","author":"Parry","year":"2005","journal-title":"World Psychiatry"},{"key":"R44-6-20210206","first-page":"17","article-title":"Addiction and HIV in Kenya: a description of treatment services and integration","volume":"6","author":"Sullivan","year":"2007","journal-title":"Afr J Drug Alcohol Stud"},{"key":"R45-6-20210206","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/S0140-6736(08)60930-7","article-title":"Oral substitution treatments for opioid dependence","volume":"371","author":"Hall","year":"2008","journal-title":"Lancet"},{"key":"R46-6-20210206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpsychores.2006.06.013","article-title":"Substance use disorders: recent advances in treatment and models of care","volume":"61","author":"Abou-Saleh","year":"2006","journal-title":"J Psychosom Res"},{"key":"R47-6-20210206","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4314\/ajpsy.v11i3.30227","article-title":"Ensuring access to psychotropic medication in Sub-Saharan Africa African","volume":"11","author":"Eaton","year":"2008","journal-title":"J Psychiatry"},{"key":"R50-6-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1468-246X.00102","article-title":"Social security systems in low-income countries: concepts, constraints and the need for cooperation","volume":"53","author":"Jutting","year":"2000","journal-title":"Int Soc Security Rev"},{"key":"R51-6-20210206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/431199","article-title":"Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature","volume":"41","author":"Ivers","year":"2005","journal-title":"HIV\/AIDS Clin Infect Dis"},{"issue":"Suppl 1","key":"R52-6-20210206","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1097\/01.aids.0000327637.59672.02","article-title":"Free care at the point of service delivery: a key component for reaching universal access to HIV\/AIDS treatment in developing countries","volume":"22","author":"Souteyrand","year":"2008","journal-title":"AIDS"},{"key":"R54-6-20210206","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1475-6773.2007.00812.x","article-title":"Role of state policies in the adoption of naltrexone for substance abuse treatment","volume":"43","author":"Heinrich","year":"2008","journal-title":"Health Serv Res"},{"key":"R55-6-20210206","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0140-6736(08)61371-9","article-title":"A developing drug problem.","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"R56-6-20210206","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(00)05065-0","article-title":"Pharmacopoeial quality of drugs supplied by Nigerian pharmacies","volume":"357","author":"Taylor","year":"2001","journal-title":"Lancet"}],"container-title":["Current Opinion in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YCO.0b013e32832a1dc0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:44:02Z","timestamp":1620978242000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001504-200905000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/yco.0b013e32832a1dc0","relation":{},"ISSN":["0951-7367"],"issn-type":[{"value":"0951-7367","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}